LASTET 50MG CAPSULE

About

Etoposide is a semisynthetic derivative of podophyllotoxin, classified as a topoisomerase II inhibitor. It exerts its cytotoxic effects by forming a ternary complex with topoisomerase II and DNA, leading to DNA strand breaks and inhibition of DNA synthesis. This action primarily occurs in the late S and G2 phases of the cell cycle, making it highly effective against rapidly proliferating cells. Lastet 50mg Capsule is indicated for the treatment of various neoplastic conditions, including small cell lung cancer, testicular cancer, and certain lymphomas and leukemias. It is often used as a crucial component in combination chemotherapy regimens. Its mechanism of action fundamentally disrupts the integrity of the cancer cell's genetic material, preventing successful replication and ultimately inducing programmed cell death (apoptosis). The oral formulation provides a convenient administration route for maintenance therapy or specific treatment protocols, allowing for outpatient management while maintaining therapeutic efficacy.

Uses

• Small cell lung cancer
• Testicular cancer
• Lymphoma
• Leukemia

Directions For Use

Take the capsule orally as directed by your physician, usually on an empty stomach. Do not chew or crush the capsule.

Benefits

• Effective against various solid tumors and hematologic malignancies.
• Oral formulation offers convenience for outpatient treatment.
• Can be used in combination with other chemotherapeutic agents.
• Targets rapidly dividing cancer cells.
• Contributes to disease remission and improved survival rates.
• Well-established efficacy in oncology protocols.

Side Effects

• Myelosuppression (low blood counts)
• Nausea and vomiting
• Hair loss (alopecia)
• Fatigue
• Diarrhea
• Oral mucositis
• Peripheral neuropathy
• Hypotension (less common with oral)
• Anaphylactic reactions (rare)
• Liver enzyme elevation
• Secondary malignancies (long-term risk)
• Fever

Safety Measures

• Alcohol - Avoid alcohol consumption as it may exacerbate gastrointestinal side effects and potentially interact with the medication's metabolism.
• Pregnancy - Contraindicated in pregnancy due to significant teratogenic and embryotoxic risks. Effective contraception is essential during treatment and for a period afterward.
• Breastfeeding - Not recommended during breastfeeding as the drug is likely excreted in breast milk and could cause serious adverse effects in the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary due to altered drug metabolism and increased toxicity risk.
• Kidney - Use with caution in patients with renal impairment; dose adjustments are often required to prevent drug accumulation and enhanced toxicity.
• Lung - Rarely, interstitial pneumonitis or pulmonary fibrosis can occur; monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.